These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Production of actinium-225 for alpha particle mediated radioimmunotherapy. Boll RA; Malkemus D; Mirzadeh S Appl Radiat Isot; 2005 May; 62(5):667-79. PubMed ID: 15763472 [TBL] [Abstract][Full Text] [Related]
8. The use of pH-triggered leaky heterogeneities on rigid lipid bilayers to improve intracellular trafficking and therapeutic potential of targeted liposomal immunochemotherapy. Karve S; Alaouie A; Zhou Y; Rotolo J; Sofou S Biomaterials; 2009 Oct; 30(30):6055-64. PubMed ID: 19665223 [TBL] [Abstract][Full Text] [Related]
9. First in vivo evaluation of liposome-encapsulated 223Ra as a potential alpha-particle-emitting cancer therapeutic agent. Jonasdottir TJ; Fisher DR; Borrebaek J; Bruland OS; Larsen RH Anticancer Res; 2006; 26(4B):2841-8. PubMed ID: 16886603 [TBL] [Abstract][Full Text] [Related]
10. Cyclotron production of Ac-225 for targeted alpha therapy. Apostolidis C; Molinet R; McGinley J; Abbas K; Möllenbeck J; Morgenstern A Appl Radiat Isot; 2005 Mar; 62(3):383-7. PubMed ID: 15607913 [TBL] [Abstract][Full Text] [Related]
11. Alpha-particle radiotherapy: For large solid tumors diffusion trumps targeting. Zhu C; Sempkowski M; Holleran T; Linz T; Bertalan T; Josefsson A; Bruchertseifer F; Morgenstern A; Sofou S Biomaterials; 2017 Jun; 130():67-75. PubMed ID: 28365545 [TBL] [Abstract][Full Text] [Related]
12. Specific targeting of human hepatocellular carcinoma cells by immunoliposomes in vitro. Moradpour D; Compagnon B; Wilson BE; Nicolau C; Wands JR Hepatology; 1995 Nov; 22(5):1527-37. PubMed ID: 7590672 [TBL] [Abstract][Full Text] [Related]
13. Disaccharide-modified liposomes and their in vitro intracellular uptake. Song CK; Jung SH; Kim DD; Jeong KS; Shin BC; Seong H Int J Pharm; 2009 Oct; 380(1-2):161-9. PubMed ID: 19635539 [TBL] [Abstract][Full Text] [Related]
15. PR_b-targeted PEGylated liposomes for prostate cancer therapy. Demirgöz D; Garg A; Kokkoli E Langmuir; 2008 Dec; 24(23):13518-24. PubMed ID: 18954096 [TBL] [Abstract][Full Text] [Related]
16. Treatment of neuroblastoma meningeal carcinomatosis with intrathecal application of alpha-emitting atomic nanogenerators targeting disialo-ganglioside GD2. Miederer M; McDevitt MR; Borchardt P; Bergman I; Kramer K; Cheung NK; Scheinberg DA Clin Cancer Res; 2004 Oct; 10(20):6985-92. PubMed ID: 15501978 [TBL] [Abstract][Full Text] [Related]
17. Actinium-225 conjugates of MAb CC49 and humanized delta CH2CC49. Kennel SJ; Brechbiel MW; Milenic DE; Schlom J; Mirzadeh S Cancer Biother Radiopharm; 2002 Apr; 17(2):219-31. PubMed ID: 12030116 [TBL] [Abstract][Full Text] [Related]
18. Sustained and specific in vitro inhibition of HIV-1 replication by a protease inhibitor encapsulated in gp120-targeted liposomes. Clayton R; Ohagen A; Nicol F; Del Vecchio AM; Jonckers TH; Goethals O; Van Loock M; Michiels L; Grigsby J; Xu Z; Zhang YP; Gutshall LL; Cunningham M; Jiang H; Bola S; Sarisky RT; Hertogs K Antiviral Res; 2009 Nov; 84(2):142-9. PubMed ID: 19699239 [TBL] [Abstract][Full Text] [Related]
19. Oxaliplatin targeting to angiogenic vessels by PEGylated cationic liposomes suppresses the angiogenesis in a dorsal air sac mouse model. Abu-Lila A; Suzuki T; Doi Y; Ishida T; Kiwada H J Control Release; 2009 Feb; 134(1):18-25. PubMed ID: 19010364 [TBL] [Abstract][Full Text] [Related]
20. Efforts to control the errant products of a targeted in vivo generator. Jaggi JS; Kappel BJ; McDevitt MR; Sgouros G; Flombaum CD; Cabassa C; Scheinberg DA Cancer Res; 2005 Jun; 65(11):4888-95. PubMed ID: 15930310 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]